• home
  • bourbon
  • links
  • blog
  • bio
  • contact form
               donstacy.com

Problems with Public Reporting of Clinical Trials

11/8/2014

 
An August 20, 2013 Journal of Clinical Oncology article by Nguyen et al entitled "Public Availability of Results of Trials Assessing Cancer Drugs in the United States" analyzed to what extent the results of completed studies of oncology drugs performed in the United States were publicly available, as required by the Food and Drug Administration Amendments Act (FDAAA), at clinicaltrials.gov or were published in medical journals.  This paper was accompanied by an editorial by Prasad et al entitled "Finishing the Picture: Problems With Public Reporting of Clinical Trials", which reviewed the paper in detail.  A close reading of these articles by a libertarian reveals an interesting statist bias.

Intriguing findings of the Nguyen et al study were as follows: (1) "Compliance with the FDAAA was higher for trials funded by industry only than those with mixed or academic funding … (20% v 11% and 6%; p < .001 …"; (2) "On multivariate analysis, industry funding only was associated with compliance with the FDAAA compared with academic funding only (adjusted odds ratio, 3.6; 95% CI, 1.8 to 6.9; p < .001) …"; and (3) "The source of funding was independently associated with compliance: trials having industry primary funding were more compliant than those with academic primary funding."

How does the editorial present these results?  "Contrary to the notion that the pharmaceutical industry might have the most to lose from clinical studies which did report negative results, compliance with the FDAAA legislation was highest in trials with industry primary funding.  This parallels the unexpected finding reported previously; namely, that pharmocoeconomic findings reported in pharmaceutical industry-funded reports were of higher quality than those findings reported by researchers who lacked pharmaceutical industry support. … It is not known if the selective incomplete reporting reflected differentials in studies with statistically nonsignificant primary or secondary outcomes or if the delayed studies were those where US Food and Drug Administration registration was being pursued and corporate interests mitigated against early dissemination."  It is difficult to interpret the editorial commentary in any other way than as a pro-State, anti-market bias.

Of course, libertarian readers recognize that the giant American pharmaceutical corporations are anything but "free market" entitles.  Rather, they are fascist organizations.  Their superior compliance with FDAAA regulations, as compared to non-commercial academic researchers, is no surprise when one considers the fact that such fascist corporations have a greater incentive (survival based on profit vs. loss) than purely State-funded academic organizations, which survive regardless of how much money they lose.

The article and editorial authors predictably recommend increased American Imperial State regulation of clinical trials reporting.  Sigh.  A libertarian's work is never done.

Comments are closed.

    LIBERTARIAN BIOETHICS BLOG

    Author

    Don Stacy is a 47 yo libertarian writer and physician.  His articles have been published by multiple libertarian-themed websites.  He practices medicine as a radiation oncologist in Hazard, KY.     

    Archives

    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011
    April 2011
    March 2011
    February 2011
    January 2011
    December 2010
    November 2010

    Categories

    All
    4 Fundamental Principles
    4 Step Heathcare Solution
    Abigail Alliance
    Abraham Lincoln
    Afterbirth Abortion
    Afterbirth Abortion 2
    Ama Bioethics Principles
    Amnesty International
    Animal Rights
    Animal Rights 2
    Banning A Risky Product
    Beneficence
    Bioethics Consults
    Blog Name
    Blog Plan
    Brain-Dead Bioethics
    Brain Dead Bioethics 2
    British Health Care
    Cancer Drugs
    C.I.A. Doctors
    Circumcision
    Classical-Liberal Bioethics
    Classical Liberal Bioethics 2
    Classical Liberal Bioethics 3
    Classical Liberal Bioethics 4
    Classical Liberal Bioethics 5
    Classical Liberal Bioethics 6
    Classical Liberal Bioethics 7
    Clinical Trials Reporting
    Clinical Trials Reporting 2
    Code Of Federal Regs
    Contractarianism
    Cooperative Groups
    Economics Of Healthcare
    Economics Of Healthcare 2
    Engelhardt And Children
    Engelhardt And Children 2
    Euthanasia
    Evidence-Based Medicine
    Facebook Ethics
    Genetic Results Return
    Genetic Results Return 2
    Guatemala S.T.D. Study
    Influenza Vaccination
    Inst. Review Boards
    Inst. Review Boards 2
    Inst. Review Boards 3
    Inst. Review Boards 4
    Inst. Review Boards 5
    Justice
    Just Price
    Kidney Sellers
    Kidney Sellers 10
    Kidney Sellers 11
    Kidney Sellers 12
    Kidney Sellers 13
    Kidney Sellers 14
    Kidney Sellers 15
    Kidney Sellers 2
    Kidney Sellers 3
    Kidney Sellers 4
    Kidney Sellers 5
    Kidney Sellers 6
    Kidney Sellers 7
    Kidney Sellers 8
    Kidney Sellers 9
    Liberation Biology
    Liberation Biology 2
    Liberation Biology 3
    Liberation Biology 4
    Liberation Biology 5
    Liberation Biology 6
    Liberation Biology 7
    Liberation Biology 8
    Liberation Biology 9
    Libertarian Bioethics
    Libertarian Premises
    Libertarian Premises 2
    Liberty Bioeth And Relig
    Liberty Bioeth And Relig 2
    Liberty Encyclopedia
    Liberty Encyclopedia 2
    Liberty Engelhardt Crit.
    Liberty Engelhardt Crit. 2
    Lives At Risk
    Lives At Risk 2
    Lives At Risk 3
    Lives At Risk 4
    Lives At Risk 5
    Lives At Risk 6
    Lives At Risk 7
    Lives At Risk 8
    Lives At Risk 9
    Mandatory Research Biopsies
    Money May Matter
    National Cancer Institute
    National Cancer Institute 2
    Neuroethics
    Nonmaleficence
    Organ Donation
    P.G.D.
    Phys. For Human Rights 1
    Phys. For Human Rights 2
    Political Triage
    Principles For Allocation
    Principles Of Bioethics
    Principles Of Bioethics 10
    Principles Of Bioethics 2
    Principles Of Bioethics 3
    Principles Of Bioethics 4
    Principles Of Bioethics 5
    Principles Of Bioethics 6
    Principles Of Bioethics 7
    Principles Of Bioethics 8
    Principles Of Bioethics 9
    Rationing Cancer Care
    Respect For Autonomy
    RTOG & NSABP
    Secrecy And Radiation
    Showing That You Care
    Sigrid Fry-Revere
    Skid Row
    Soviet Medicine
    Soviet Medicine 2
    Test
    The Carriage-Trade Trend
    The Chemist's War
    The Expanding Circle
    The Expanding Circle 2
    The Expanding Circle 3
    The Expanding Circle 4
    The Expanding Circle 5
    The Expanding Circle 6
    The Expanding Circle 7
    The Expanding Circle 8
    The Expanding Circle 9
    The Nathaniel Centre
    Tuskegee Syphilis Study
    U.N.E.S.C.O.
    U.S. Human Experiments
    U.S. Medical Experiments
    Warning Labels
    What It Feels Like
    What It Feels Like 2
    What It Feels Like 3
    Why Health Is Not Special

    RSS Feed

    Picture
    ANARCHO-CAPITALIST FLAG
Web Hosting by IPOWER